Abbott soars 10% after its 15-minute COVID-19 test wins FDA approval (ABT) | Markets Insider

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 51%

Finance Finance Headlines News

Finance Finance Latest News,Finance Finance Headlines

Abbott soars 10% after its 15-minute COVID-19 test wins FDA approval

Abbott's test, BinaxNOW, is a COVID-19 diagnostic test that can deliver results in 15 minutes without the use of lab equipment. The test will cost just $5, according to Abbott.The new COVID test will be accompanied by a free smartphone app that will display a user's test results, which can then be displayed when asked at social gathering places like schools and workplaces.

According to Abbott, the BinaxNOW test delivered sensitivity of 97.1% and accuracy of 98.5% in a clinical study. Abbott isn't the only company that received FDA emergency authorization for a potential game-changing COVID-19 test this week. for its saliva-based COVID-19 test, allowing patients to avoid the more invasive nasal swab test that has been used since the outbreak began earlier this year.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 729. in FİNANCE

Finance Finance Latest News, Finance Finance Headlines